Top officials at the FDA's Center for Biologics Evaluation and Research, responsible for approving vaccines and gene therapies, have been leaving or forced out, causing concern for future drug approvals. The recent departures risk weakening the agency's ability to approve crucial medical products and could impact public health.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay